EGFR MUTATIONS IN NSCLC PATIENTS IN CENTRAL EUROPE: THE INSIGHT OBSERVATIONAL STUDY

被引：0

作者：

Pirker, Robert ^{[1
]}

Dziadziuszko, Rafal ^{[2
]}

Berzinec, Peter ^{[3
]}

Dusek, Ladislav ^{[4
]}

Cufer, Tanja ^{[5
]}

Bajcic, Paolo ^{[6
]}

Popper, Helmut ^{[7
]}

Olszewski, Wlodzimierz ^{[8
]}

Chorostowska-Wynimko, Joanna ^{[9
]}

Skrickova, Jana ^{[10
]}

Kolek, Vitezslav ^{[11
]}

Pesek, Milos ^{[12
]}

Ostoros, Gyula ^{[13
]}

Chmielewska, Izabela ^{[14
]}

Medvecova, Lenka ^{[15
]}

Eisterer, Wolfgang ^{[16
]}

Kandrnal, Vit ^{[4
]}

Mazal, Juraj ^{[17
]}

Popper, Helmuth ^{[7
]}

Olszewski, Wlodzimierz ^{[8
]}

Ramlau, Rodryg ^{[18
]}

机构：

[1] Med Univ Vienna, Dept Med 1, Vienna, Austria

[2] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland

[3] Specialised Hosp St Zoerardus Zobor, Dept Oncol, Nitra, Slovakia

[4] Masaryk Univ, Inst Biostat & Anal, CS-60177 Brno, Czech Republic

[5] Univ Clin Golnik, Med Oncol Unit, Golnik, Slovenia

[6] Boehringer Ingelheim Rcv, Med Affairs Dept, Vienna, Austria

[7] Med Univ Graz, Dept Pathol, Graz, Austria

[8] Oncol Inst Maria Sklodowska Curie, Dept Pathol, Krakow, Poland

[9] Natl Inst TB & Lung Dis, Lab Mol Diagnost & Immunol, Warsaw, Poland

[10] Univ Hosp, Dept Pulm Dis & TB, Prague, Czech Republic

[11] Univ Hosp Olomouc, Dept Resp Med, Olomouc, Czech Republic

[12] Univ Hosp Plze, Dept Pulm Dis & TB, Plzen, Czech Republic

[13] Natl Koranyi Inst Pulmonol, Dept 8, Budapest, Hungary

[14] Med Univ, Dept Pneumol Oncol & Allergol, Gdansk, Poland

[15] Adus Healthcare Ctr, Dept Oncol, Bratislava, Slovakia

[16] Med Univ Innsbruck, Dept Med, A-6020 Innsbruck, Austria

[17] Univ Hosp FD Roosevelt, Dept Pneumol, Bratislava, Slovakia

[18] Poznan Univ Med Sci, Dept Oncol, Poznan, Poland

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.11-018

引用

页码：S897 / S897

页数：1

共 50 条

[41] Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations
Hayashi, Hidetoshi
Nadal, Ernest
Gray, Jhanelle E.
Ardizzoni, Andrea
Caria, Nicola
Puri, Tarun
Grohe, Christian
CLINICAL LUNG CANCER, 2022, 23 (01) : E69 - E82
[42] Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene
Nicos, Marcin
Sroka-Bartnicka, Anna
Kalinka, Ewa
Krawczyk, Pawel
CANCERS, 2025, 17 (04)
[43] Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
Passaro, Antonio
Prelaj, Arsela
Bonanno, Laura
Tiseo, Marcello
Tuzi, Alessandro
Proto, Claudia
Chiari, Rita
Rocco, Danilo
Genova, Carlo
Sini, Claudio
Cortinovis, Diego
Pilotto, Sara
Landi, Lorenza
Bennati, Chiara
Camerini, Andrea
Toschi, Luca
Putzu, Carlo
Cerea, Giulio
Spitaleri, Gianluca
Cappuzzo, Federico
de Marinis, Filippo
CLINICAL LUNG CANCER, 2019, 20 (02) : E186 - E194
[44] Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations
Bazhenova, Lyudmila
Minchom, Anna
Viteri, Santiago
Bauml, Joshua M.
Ou, Sai-Hong Ignatius
Gadgeel, Shirish M.
Manuel Trigo, Jose
Backenroth, Daniel
Li, Tracy
Londhe, Anil
Mahadevia, Parthiv
Girard, Nicolas
LUNG CANCER, 2021, 162 : 154 - 161
[45] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
Xiong, Liwen
Cui, Shaohua
Ding, Jingyan
Sun, Yun
Zhang, Longfu
Zhao, Yizhuo
Gu, Aiqin
Chu, Tianqing
Wang, Huimin
Zhong, Hua
Ye, Xin
Gu, Yi
Zhang, Xin
Hu, Min
Jiang, Liyan
ONCOTARGET, 2017, 8 (38) : 63846 - 63856
[46] Monitoring Plasma EGFR Mutations during First Line Treatment with EGFR TKIs in NSCLC Patients
Mohorcic, Katja
Kern, Izidor
Janzic, Urska
Hitij, Nina Turnsek
Rot, Mitja
Cufer, Tanja
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S388 - S389
[47] ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations
Wang, Zhijie
Li, Zhenxiang
Ding, Xiaosheng
Shen, Zhirong
Liu, Zhentao
An, Tongtong
Duan, Jianchun
Zhong, Jia
Wu, Meina
Zhao, Jun
Zhuo, Minglei
Wang, Yuyan
Wang, Shuhang
Sun, Yu
Bai, Hua
Wang, Jie
SCIENTIFIC REPORTS, 2015, 5
[48] ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations
Zhijie Wang
Zhenxiang Li
Xiaosheng Ding
Zhirong Shen
Zhentao Liu
Tongtong An
Jianchun Duan
Jia Zhong
Meina Wu
Jun Zhao
Minglei Zhuo
Yuyan Wang
Shuhang Wang
Yu Sun
Hua Bai
Jie Wang
Scientific Reports, 5
[49] Routine detection of EGFR mutations in patients with NSCLC: A comparative study of three alternative methods in 105 patients.
Zalcman, G.
Richard, N.
Hardouin, A.
Gervais, R.
Antoine, M.
Mittre, H.
Baumann, J. J.
Galateau-Salle, F.
Cadranel, J.
Kottler, M.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 410S - 410S
[50] Clinical outcomes in patients with EGFR mutations: pooled analysis of NSCLC patients treated with either an EGFR TKI or chemotherapy
Paz-Ares, L.
Soulieres, D.
Klughammer, B.
Melezinek, I.
Moecks, J.
Keil, L.
Mok, T.
EJC SUPPLEMENTS, 2009, 7 (02): : 551 - 552

← 1 2 3 4 5 →